SEB Asset Management’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
BBA
SEB Asset Management's PRAX Position: Q3 2026 in Review
SEB Asset Management held its Praxis Precision Medicines (PRAX) position steady in Q3 2026 at 42,705 shares worth $12.4M. The position accounts for 0.05% of the portfolio, ranked #289.
SEB Asset Management first reported a position in PRAX in Q2 2026 and has held it in 2 quarters since. The position peaked at $14.3M in Q2 2026. 338 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- SEB Asset Management held 42,705 shares of Praxis Precision Medicines worth $12.4M as of Q3 2026.
- SEB Asset Management left its Praxis Precision Medicines share count unchanged in Q3 2026.
- Praxis Precision Medicines made up 0.05% of SEB Asset Management's portfolio in Q3 2026, its #289 holding.
- SEB Asset Management first reported a position in Praxis Precision Medicines in Q2 2026 and has held it in 2 quarters since.
- SEB Asset Management's Praxis Precision Medicines position peaked at $14.3M in Q2 2026.
- 338 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.